Creatine for the Treatment of Amyotrophic Lateral Sclerosis
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
Creatine is a naturally occurring chemical involved in the production of energy in muscle.
Abnormalities in creatine have been linked to the progression of degenerative neuromuscular
diseases such as amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease). This study
will test whether taking creatine can improve the symptoms of ALS.
Phase:
Phase 2
Details
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)